Ann E. Taylor, M.D.
In her current role as CMO, Dr. Taylor is accountable for regulatory systems and strategy, patient safety and R&D quality assurance across AstraZeneca’s entire portfolio. Previously, she was VP of global clinical development at Medimmune, the biologics R&D division of AstraZeneca. She has also held senior roles at Novartis and Pfizer.
- October 2021
Added to: Unlearn - San Francisco, CA
Unlearn uses AI to create Digital Twins for clinical research, enabling drug developers in clinical development to accelerate timelines, increase confidence, and enhance clinical decision making.